Similar articles

• Prognostic factors in nonseminomatous testicular cancer.

  Javadpour N. Javadpour N. Prog Clin Biol Res. 1985;203:271-86. Prog Clin Biol Res. 1985. PMID: 2421330 No abstract available.
• Prognostic factors in metastatic disease.

  Droz JP, Kramar A, Rey A. Droz JP, et al. Semin Oncol. 1992 Apr;19(2):181-9. Semin Oncol. 1992. PMID: 1372760 No abstract available.
• Treatment options for stage I nonseminoma.

  Feldman DR. Feldman DR. J Clin Oncol. 2014 Dec 1;32(34):3797-800. doi: 10.1200/JCO.2014.56.8006. Epub 2014 Nov 3. J Clin Oncol. 2014. PMID: 25366681 Review. No abstract available.
• Serum tumor markers and testicular germ cell tumors: a primer for radiologists.

  Marshall C, Enzerra M, Rahnemai-Azar AA, Ramaiya NH. Marshall C, et al. Abdom Radiol (NY). 2019 Mar;44(3):1083-1090. doi: 10.1007/s00261-018-1846-z. Abdom Radiol (NY). 2019. PMID: 30539249 Review.
• NCCN clinical practice guidelines in oncology: testicular cancer.

  Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J, Wang J. Motzer RJ, et al. J Natl Compr Canc Netw. 2009 Jun;7(6):672-93. doi: 10.6004/jnccn.2009.0047. J Natl Compr Canc Netw. 2009. PMID: 19555582 No abstract available.